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Background: 
 
Cardiac troponin is the preferred biomarker of acute coro-
nary syndrom (ACS) and a reliable indicator of mortality in many other clin-
ical settings. It is routinely used for the assessment of patients admitted in
Emergency Departments (ED) even in the absence of clinical suspicion of
acute coronary syndrome (ACS). The clinical interest of such practice remains
to be determined.
 
Methods: 
 
295 consecutive patients admitted for various medical conditions
in our ED from January to June 2009 have been enrolled on the basis of high
troponin I level in their first blood sample (> 0.08 µg/l) and followed up for
survival until April 2010. Population was divided into two groups according
to the etiology of troponin elevation: group 1 when ACS; group 2 when no
criteria of ACS with or without alternative diagnosis for high troponin level.
 
Results:
 
 Final diagnosis for troponin elevation was ACS in 62 patients
(21%) and non ACS in 233 (79%). Forty six % had neither chest pain nor
ECG ischemic changes. Mean age was 69 +/-13 years in group 1 and 78+/- 13
in group 2.
In group 2, high troponin level was related to congestive heart failure or
arythmia in 41% of cases, sepsis 22%, acute respiratory failure 7%, stroke 5%,
miscellaneous 10% (myopericarditis n=3, Takotsubo n=5, rhabdomyolysis
n=4, pulmonary embolism n=5, haemorrhage n=6) and undetermined 15%. 
Hospital mortality was 12.5% in group 1 and 37 % in group 2. Overall sur-
vival at 12 months was 59% in group 2 compared to 85% for patients with
ACS. After multivariate analysis age, creatinine and BNP level were predic-
tors of survival. The variable ACS versus non ACS was not an independent
factor.
 
Conclusion: 
 
In ED, troponin is currently used in patients with of a low
probability of ACS. Troponin elevation is mainly due to medical conditions
other than ACS. When compared with the ACS group, the worse prognosis of
the non ACS patients appears to be strongly correlated to clinical variables
such as age, renal function and severe associated diseases. In conclusion risk
stratification of patients without ACS should first be based on clinical data
because troponin elevation elicits diagnosis confusion.
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Background:
 
 Cardiac troponin is the gold standard for the diagnosis and
risk stratification in acute coronary syndrome (ACS). Troponin elevation asso-
ciated with symptomatic paroxysmal reentrant supraventricular tachycardia
(PSVT) has been described in short series but long term prognosis has not
been yet reported. 
The aim of the present study was to evaluate the diagnostic and prognostic
value of troponin I elevation following PSVT. 
 
Methods and results:
 
 From January 2003 to September 2009, all consec-
utive patients (n=27, 52% females, median age 52 years) admitted for PSVT
and troponin I elevation (mean 0.42 µg/l, range: 0.19-5.9 ) were included. 
None of the patients had a history of CAD. Thirteen patients (48.1%) were
current smokers and 9 (33.3%) had no cardiovascular risk factor. All patients
had narrow QRS during PSVT and the aetiology was nodal reentrant tachy-
cardia in all except for one patient with preexcitation morphology in sinus
rhythm. 
Coronary angiogram has been performed in 25 patients. Twenty three had
angiographically normal coronary arteries. A single vessel disease (coronary
stenosis >50%) was found in 2 patients and maximal stress echocardiography
was normal in both patients. Two patients who declined coronary angiogram
had normal maximal stress echocardiography. 
During follow-up (median 43 months, range: 4- 82), none of the patients
experienced ACS or cardiac death. One of the patients died from cancer after
63 months of follow up. Recurrence of PSVT requiring medical intervention
occurred in 4 (14.8%) patients, atrial fibrillation in 3 (11%) patients and
radiofrequency catheter ablation of atrioventricular nodal reciprocating tachy-
cardia had been performed in 5 (18.5%) patients. 
 
Conclusions:
 
 Troponin I elevation following PSVT is common, not related
to obstructive CAD or plaque rupture and is not associated with adverse short
and long term prognosis.
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Purpose:
 
 Elevated troponin is frequent in acute ischaemic stroke but its
clinical implication remain unclear.The aim of this study is to describe preva-
lence, predictive factors and prognosis of patients with troponin elevation in
acute ischaemic stroke. A second end point was to diagnose a potential
ischaemic heart disease with cardiac magnetic resonance imaging (MRI) per-
formed in ten days after stroke.  
 
Methods:
 
 146 consecutive patients admitted for acute ischaemic stroke  in
our stroke unit were prospectively enrolled  between july and november 2009.
The blood troponin Ic was measured in the first two days after admission.
Clinical and biological data, stroke severity attested by national institute of
health stroke scale (NHISS) and in-hospital mortality were compared between
the two groups with and without troponin elevation.A cardiac MRI was per-
formed during hospitalization if troponin was positive. 
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